Akebia Therapeutics Appoints Erik Ostrowski as Chief Financial Officer and Chief Business Officer
CAMBRIDGE, Mass., June 24, 2024 /PRNewswire/ -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better...
CAMBRIDGE, Mass., June 24, 2024 /PRNewswire/ -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better...
TALLAHASSEE, Fla., May 29, 2024 /PRNewswire/ -- F&I Sentinel, a leading risk-management solutions provider for finance and insurance products in...